-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Bristol Myers Squibb Co quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Bristol Myers Squibb Co Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$398M, a 82.6% decline year-over-year.
- Bristol Myers Squibb Co Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $109M, a 84.9% decline year-over-year.
- Bristol Myers Squibb Co annual Income Tax Expense (Benefit) for 2023 was $400M, a 70.8% decline from 2022.
- Bristol Myers Squibb Co annual Income Tax Expense (Benefit) for 2022 was $1.37B, a 26.2% increase from 2021.
- Bristol Myers Squibb Co annual Income Tax Expense (Benefit) for 2021 was $1.08B, a 49% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)